| Product Code: ETC6143197 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Nucleic Acid Therapeutics CDMO Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Nucleic Acid Therapeutics CDMO Market - Industry Life Cycle |
3.4 Argentina Nucleic Acid Therapeutics CDMO Market - Porter's Five Forces |
3.5 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.7 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
3.8 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Argentina Nucleic Acid Therapeutics CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in Argentina |
4.2.2 Growing investment in RD for nucleic acid therapeutics |
4.2.3 Rising demand for personalized medicine in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for nucleic acid therapeutics |
4.3.2 High costs associated with nucleic acid therapeutics development and manufacturing |
4.3.3 Limited expertise and infrastructure for nucleic acid therapeutics CDMO services |
5 Argentina Nucleic Acid Therapeutics CDMO Market Trends |
6 Argentina Nucleic Acid Therapeutics CDMO Market, By Types |
6.1 Argentina Nucleic Acid Therapeutics CDMO Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.4 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By RNA-based Therapies, 2021- 2031F |
6.2 Argentina Nucleic Acid Therapeutics CDMO Market, By Service |
6.2.1 Overview and Analysis |
6.2.2 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Process Development and Optimization, 2021- 2031F |
6.2.3 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Manufacturing Services, 2021- 2031F |
6.2.4 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Analytical and Quality Control Services, 2021- 2031F |
6.2.5 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Argentina Nucleic Acid Therapeutics CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.3.3 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Government & Academic Research Institutes, 2021- 2031F |
6.3.4 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.4 Argentina Nucleic Acid Therapeutics CDMO Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Oncology, 2021- 2031F |
6.4.3 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Genetic Disorders, 2021- 2031F |
6.4.4 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.4.5 Argentina Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Argentina Nucleic Acid Therapeutics CDMO Market Import-Export Trade Statistics |
7.1 Argentina Nucleic Acid Therapeutics CDMO Market Export to Major Countries |
7.2 Argentina Nucleic Acid Therapeutics CDMO Market Imports from Major Countries |
8 Argentina Nucleic Acid Therapeutics CDMO Market Key Performance Indicators |
8.1 Number of clinical trials utilizing nucleic acid therapeutics in Argentina |
8.2 Percentage of healthcare facilities adopting nucleic acid therapeutics |
8.3 Investment in nucleic acid therapeutics research and development in Argentina |
9 Argentina Nucleic Acid Therapeutics CDMO Market - Opportunity Assessment |
9.1 Argentina Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Argentina Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.3 Argentina Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
9.4 Argentina Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Argentina Nucleic Acid Therapeutics CDMO Market - Competitive Landscape |
10.1 Argentina Nucleic Acid Therapeutics CDMO Market Revenue Share, By Companies, 2024 |
10.2 Argentina Nucleic Acid Therapeutics CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here